Perritt Capital Management Inc Pro Phase Labs, Inc. Transaction History

Perritt Capital Management Inc

$185 Million
Q3 2024

A detailed history of Perritt Capital Management Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Perritt Capital Management Inc holds 82,932 shares of PRPH stock, worth $57,223. This represents 0.11% of its overall portfolio holdings.

Number of Shares

82,932

Previous 85,500 3.0%

Holding current value

$57,223

Previous $357,000 43.98%

% of portfolio

0.11%

Previous 0.21%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.16 - $4.06 $5,546 - $10,426	-2,568 Reduced 3.0%	82,932 $200,000
Q2 2024 Aug 07, 2024	SELL	$4.18 - $7.35 $836 - $1,470	-200 Reduced 0.23%	85,500 $357,000
Q1 2024 May 15, 2024	SELL	$4.47 - $6.47 $894 - $1,294	-200 Reduced 0.23%	85,700 $554,000
Q4 2023 Feb 14, 2024	SELL	$4.35 - $5.1 $27,839 - $32,639	-6,400 Reduced 6.93%	85,900 $388,000
Q3 2023 Nov 14, 2023	SELL	$4.23 - $7.53 $21,150 - $37,650	-5,000 Reduced 5.14%	92,300 $403,000
Q4 2022 Feb 14, 2023	SELL	$8.78 - $12.47 $221,255 - $314,244	-25,200 Reduced 20.57%	97,300 $936,000
Q3 2022 Nov 14, 2022	SELL	$8.96 - $14.7 $182,784 - $299,880	-20,400 Reduced 14.28%	122,500 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$6.52 - $13.24 $427,060 - $867,220	-65,500 Reduced 31.43%	142,900 $1.81 Million
Q1 2022 May 16, 2022	SELL	$6.2 - $7.87 $2,480 - $3,148	-400 Reduced 0.19%	208,400 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $104,652 - $160,956	20,400 Added 10.83%	208,800 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$4.89 - $7.82 $51,345 - $82,110	10,500 Added 5.9%	188,400 $980,000
Q2 2021 Aug 16, 2021	BUY	$4.61 - $6.83 $611,908 - $906,580	132,735 Added 293.89%	177,900 $1.1 Million
Q1 2021 May 17, 2021	BUY	$6.19 - $16.0 $279,571 - $722,640	45,165 New	45,165 $334,000

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.71M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $11.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Pro Phase Labs, Inc. Transaction History